Inspire Medical Systems, Inc. (NYSE:INSP) Receives $233.58 Consensus PT from Analysts

Shares of Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $233.58.

A number of analysts have recently commented on INSP shares. Bank of America upgraded Inspire Medical Systems from a "neutral" rating to a "buy" rating and boosted their price target for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Stifel Nicolaus reaffirmed a "hold" rating and set a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. KeyCorp lowered their price objective on shares of Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating on the stock in a report on Wednesday, August 7th. Royal Bank of Canada restated an "outperform" rating and set a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Finally, Robert W. Baird lifted their price target on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an "outperform" rating in a research note on Tuesday, November 5th.

Insider Buying and Selling

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the firm's stock in a transaction on Monday, September 9th. The stock was sold at an average price of $220.00, for a total transaction of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares of the company's stock, valued at $5,090,800. This trade represents a 3.34 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Inspire Medical Systems

Several institutional investors and hedge funds have recently modified their holdings of INSP. Synovus Financial Corp grew its position in shares of Inspire Medical Systems by 7.5% in the third quarter. Synovus Financial Corp now owns 3,502 shares of the company's stock valued at $739,000 after purchasing an additional 244 shares during the last quarter. Tidal Investments LLC bought a new position in Inspire Medical Systems during the 3rd quarter worth $320,000. Teachers Retirement System of The State of Kentucky lifted its holdings in shares of Inspire Medical Systems by 20.1% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 49,178 shares of the company's stock worth $10,379,000 after buying an additional 8,240 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Inspire Medical Systems by 0.7% in the third quarter. Geode Capital Management LLC now owns 483,654 shares of the company's stock valued at $102,102,000 after acquiring an additional 3,128 shares during the period. Finally, M&T Bank Corp grew its stake in shares of Inspire Medical Systems by 53.1% in the third quarter. M&T Bank Corp now owns 3,228 shares of the company's stock valued at $681,000 after acquiring an additional 1,120 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Inspire Medical Systems Stock Up 5.7 %

Shares of INSP traded up $10.81 on Monday, hitting $199.55. The company's stock had a trading volume of 594,575 shares, compared to its average volume of 598,290. The firm's fifty day moving average price is $199.53 and its 200-day moving average price is $175.40. Inspire Medical Systems has a fifty-two week low of $123.00 and a fifty-two week high of $257.40. The firm has a market capitalization of $5.98 billion, a price-to-earnings ratio of 176.38 and a beta of 1.36.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The firm's revenue was up 32.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.29) earnings per share. As a group, equities analysts predict that Inspire Medical Systems will post 1.33 earnings per share for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.